Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection

American Journal of Gastroenterology

Volumn 95, Issue 5, 2000, Pages 1316-1322

  Rodriguez Mendez M L ^a   Gonzalez Quintela A ^a   Aguilera, A ^a   Barrio, E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0343130530     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00773-5     Document Type: Article

References (67)

1. Conte D., Ferroni P., Lorini G., et al. HIV, and HBV infection in intravenous drug addicts from northeastern Italy. J Med Virol. 22:1987;299-306.
2. Díaz Portillo J., García-Martos P., Alvarez Rojas C., et al. Infección por los virus de la hepatitis B, C y delta en portadores del virus de la inmunodeficiencia humana. Med Clin (Barc). 96:1991;245-247.
3. Van Ameijden E.J.C., Van den Hoek J.A.R., Mientjes G.H.C., et al. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 9:1993;255-262.
4. Ranger S., Aussel L., Weinbreck P., et al. Séroprévalence de l'hepatite C chez les sujets contaminés par le virus de l'inmunodéficence humaine. Path Biol. 39:1991;126-130.
5. Francisci D., Baldelli F., Papili R., et al. Prevalence of HBV, HDV, and HCV hepatitis markers in HIV-positive patients. Eur J Epidemiol. 11:1995;123-126.
6. Eskild A., Magnus P., Petersen G., et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS. 6:1992;571-574.
7. Sinicco A., Raitieri R., Sciandra M., et al. Coinfection and superinfection of hepatitis B virus in patients infected with human immunodeficiency virus No evidence of faster progression to AIDS . Scand J Infect Dis. 29:1997;111-115.
8. Gilson R.J., Hawkins A.E., Beecham M.R., et al. Interactions between HIV, and hepatitis B in homosexual men Effects on the natural history of infection . AIDS. 11:1997;597-606.
9. Ockenga J., Tillmann H.L., Trautwein C., et al. Hepatitis B, and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol. 27:1997;18-24.
10. Bodsworth N.J., Cooper D.A., Donovan B. The influence of human immunodeficiency virus type 1 on the development of the hepatitis B virus carrier state. J Infect Dis. 163:1991;1138-1140.
11. Milich D.R., Chisari F.V. Genetic regulation of immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral response to the a and d determinants of HBsAg. J Immunol. 129:1982;320-325.
12. Biggar R.J., Goedert J.J., Hoofnagle J. Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med. 31:1987;630-631.
13. Drake J.H., Parmley R.T.W., Britton H.A. Loss of hepatitis B antibody in human immunodeficiency virus-positive hemophilia patients. Pediatr Infect Dis J. 6:1987;1051-1054.
14. Laukamm-Josten U., Müller O., Bienzle U., et al. Decline of naturally acquired antibodies to hepatitis B surface antigen in HIV-1 infected homosexual men. AIDS. 2:1988;400-401.
15. Homann C., Krogsgaard K., Pedersen C., et al. High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J Acquir Immune Defic Syndr. 4:1991;416-420.
16. Hadler S.C., Judson F.N., O'Malley P.M., et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis. 163:1991;454-459.
17. Bodsworth N., Donovan B., Nightingale B.N. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B A study of 150 homosexual men . J Infect Dis. 160:1989;577-582.
18. Perrillo R.P., Regenstein F.G., Roodman S.T. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med. 105:1986;382-383.
19. Krogsgaard K., Lindhardt B.O., Nielsen J.O., et al. The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology. 7:1987;37-41.
20. Goldin R.D., Fish D.E., Hay A., et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. J Clin Pathol. 43:1990;203-205.
21. Mills C.T., Lee E., Perrillo R. Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B. Gastroenterology. 99:1990;519-524.
22. Colin J.F., Cazals-Hatem D., Loriot M.A., et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 4:1999;1306-1310.
23. Koziol D.E., Alter H.J., Kirchener J.P., et al. The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. J Immunol. 117:1976;2260-2262.
24. Roche B., Samuel D., Gigou M., et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 26:1997;517-526.
25. Dusheiko G.W., Song E., Bowyer S., et al. Natural history of hepatitis B virus infection in renal transplant recipients A fifteen year follow-up . Hepatology. 3:1983;330-336.
26. Dhedin N., Douvin C., Kuentz M., et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation A retrospective study of 37 patients with pretrasplant anti-HBs and anti-HBc . Transplantation. 66:1998;616-619.
27. Lok A.S.F., Liang R.H.S., Chiu E.K.W., et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology. 100:1991;182-188.
28. Grümayer E.R., Panzer S., Ferenci P., et al. Recurrence of hepatitis B in children with serologic evidence of past hepatitis B virus infection undergoing antileukemic chemotherapy. J Hepatol. 8:1989;232-235.
29. Ahmed A., Keefe E.B. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol. 94:1999;249-251.
30. Lazizi Y., Grangeot-Keros L., Delfraissy J.F., et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type I. J Infect Dis. 158:1988;666-667.
31. Lazizi Y., Grangeot-Keros L., Pillot J. Reactivation of hepatitis B. Lancet. 2:1989;172.
32. Vento S., Di Perri G., Luzzati M., et al. Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet. 1:1989;332-333.
33. Vento S., Di Perri G., Garofano T., et al. Reactivation of hepatitis B in AIDS. Lancet. 2:1989;108-109.
34. Gilson R.J.C., Tedder R.S., Weller I.V.D. Hepatitis B Reactivation or reinfection associated with HIV-1 infection . Lancet. 2:1989;1330.
35. Maeland A., Skaug K., Storvold G. Reactivation of hepatitis B. Lancet. 1:1989;1083.
36. Vandercam B., Cornu C., Gala J.L., et al. Reactivation of hepatitis B virus in a previously immune patient with human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis. 9:1990;701-702.
37. Ortiz-Interian C.J., de Medina M.D., Perez G.O., et al. Recurrence and clearance of hepatitis B surface antigenemia in a dialysis patient infected with the human immunodeficiency virus. Am J Kidney Dis. 16:1990;154-156.
38. Waite J., Gilson R.J.C., Weller I.V.D., et al. Hepatitis B virus reactivation or reinfection associated with HIV-1 infection. AIDS. 2:1988;443-448.
39. Altfeld M., Rockstroh J.K., Addo M., et al. Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal. J Hepatol. 29:1998;306-309.
40. García F., García F., Bernal M.C., et al. Evaluation of enzyme immunoassay for hepatitis B virus DNA based on anti-double-strand DNA. J Clin Microbiol. 33:1995;413-415.
41. Bayas J.M., Bruguera M., Martín V., et al. Hepatitis B vaccination in prisons. The Catalonian experience. Vaccine. 11:1993;1441-1444.
42. Santana Rodríguez O.E., Male Gil M.L., Hernández Santana J.F., et al. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol. 14:1998;555-561.
43. Castro Iglesias M.A., Pedreira J.D., de Miguel J., et al. Aspectos epidemiológicos de la infección por el virus de la inmunodeficiencia humana en la comunidad Gallega. Med Clin (Barc). 91:1988;406-408.
44. Stark K., Müller R., Bienzle U., et al. Frontloading A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin . AIDS. 10:1996;311-317.
45. León P., López J.A., Contreras G., et al. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain. Eur J Clin Microbiol Infect Dis. 7:1988;533-535.
46. Mezzelani P., Quaglio G., Venturini L., et al. The significance of the isolated anti-HBc carrier. A study of 1797 drug addicts. The Interset Group of Scientific Collaboration. Recenti Prog Med. 85:1994;419-424.
47. Davaro R.E., Cheeseman S.H., Keroack M.A., et al. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. Clin Infect Dis. 23:1996;189-190.
48. Vázquez-Vizoso F., Eiroa P., Ledo L., et al. HIV infection, and isolated detection of anti-HBc. Gastroenterology. 106:1994;823-824.
49. Opravil M., Hunziker R., Luthy R., et al. Chronic hepatitis B, and C in HIV-infected patients. Dtsch Med Wochenschr. 123:1998;753-760.
50. McMahon B.J., Parkinson A.J., Helminiak C., et al. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology. 103:1992;590-594.
51. Kroes A.C.M., Quint W.G.V., Heijtink R.A. Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population. J Med Virol. 35:1991;96-100.
52. Hoofnagle J.H., Seefe L.B., Bales Z.B., et al. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med. 298:1978;1379-1383.
53. Diamantis I.D., McGandy C., Pult I., et al. Polymerase chain reaction detects hepatitis B virus DNA in paraffin-embedded liver tissue from patients sero- and histo-negative for active hepatitis B. Virchows Archiv A Pathol Anat. 420:1992;11-15.
54. Féray C., Zignego A.L., Samuel D., et al. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. The liver transplantation model. Transplantation. 49:1990;1155-1158.
55. Seeling R., Renz M., Seeling H.P. PCR in the diagnosis of viral hepatitis. Ann Med. 24:1992;225-230.
56. Wang J.T., Wang T.H., Sheu J.C., et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis. 163:1991;397-399.
57. Douglas D.D., Taswell H.F., Rakela J., et al. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion. 33:1993;212-216.
58. Jilg W., Sieger E., Zachoval R., et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection High percentage of carriers of hepatitis B and C virus . J Hepatol. 23:1995;14-20.
59. Luo K.X., Zhou R., He C., et al. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol. 35:1991;55-59.
60. Gross A., Joller-Jemelka H.I., Wicki A.N., et al. Hepatitis serological finding "anti-HBc alone," circulating viral DNA and interpretation of findings. Schweiz Med Wochenschr. 123:1993;1193-1202.
61. Sanchez-Quijano A., Jauregui J.I., Leal M., et al. Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol. 17:1993;288-293.
62. Lok A.S.F., Lai C.L., Wu P.C. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection Implications in hepatitis B vaccination programs . Hepatology. 8:1988;766-770.
63. Zito D.R., Gurdak R.G., Tucker F.L., et al. Hepatitis B virus serology. Loss of antibody to surface antigen. Am J Clin Pathol. 88:1987;229-231.
64. Collier A.C., Corey L., Murphy V.L., et al. Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med. 109:1988;101-105.
65. Loke R.H.T., Murray-Lyon I., Coleman J.C., et al. Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody An indicator of poor prognosis . J Med Virol. 31:1990;109-111.
66. Noonan C.A., Yoffe B., Mansell P.W.A., et al. Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA. 83:1986;5698-5702.
67. Clementi M., Manzin A., Bagnarelli P., et al. Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. Arch Virol. 126:1992;1-9.